THE EVALUATION OF ACUTE PYELONEPHRITIS AND RENAL SCARRING WITH TECHNETIUM 99M-DIMERCAPTOSUCCINIC ACID RENAL SCINTIGRAPHY - EVOLVING CONCEPTS AND FUTURE-DIRECTIONS
Hg. Rushton, THE EVALUATION OF ACUTE PYELONEPHRITIS AND RENAL SCARRING WITH TECHNETIUM 99M-DIMERCAPTOSUCCINIC ACID RENAL SCINTIGRAPHY - EVOLVING CONCEPTS AND FUTURE-DIRECTIONS, Pediatric nephrology, 11(1), 1997, pp. 108-120
Technetium 99m-dimercaptosuccinic acid (DMSA) scintigraphy has emerged
as the imaging agent of choice for the detection and evaluation of ac
ute pyelonephritis and renal cortical scarring in children. Consequent
ly, DMSA scintigraphy provides a unique opportunity to study the progr
ession of renal damage and functional loss from the initial insult of
acute pyelonephritis to the subsequent development of irreversible ren
al scarring. Over the last few years, clinical and experimental invest
igations using DMSA renal scintigraphy have provided new insights into
the etiology, pathophysiology, and clinical outcome of acute pyelonep
hritis in children. These studies have confirmed the primary role of t
he acute inflammatory response, associated with both reflux and nonref
lux pyelonephritis, in the etiology of irreversible renal scarring. Fu
rthermore, several studies have shown that renal scarring can be preve
nted or diminished by the early diagnosis and treatment of pyelonephri
tis. This review highlights these recent observations and makes recomm
endations regarding current clinical and future research applications.